Correction to: MET receptor serves as a promising target in melanoma brain metastases. Redmer T, Schumann E, Peters K, Weidemeier ME, et al. Acta Neuropathol 2024;147:63.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Redmer T, Schumann E, Peters K, Weidemeier ME, et al. Correction to: MET receptor serves as a promising target in melanoma brain metastases. Acta Neuropathol 2024;147:63.
PMID: 38536477